Detalles de la búsqueda
1.
Long-term efficacy and safety of tucidinostat in patients with relapsed or refractory peripheral T-cell lymphoma: final analysis of phase IIb results.
Haematologica
; 2024 Jun 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-38841789
2.
Expanded natural killer cells potentiate the antimyeloma activity of daratumumab, lenalidomide, and dexamethasone in a myeloma xenograft model.
Cancer Immunol Immunother
; 72(5): 1233-1246, 2023 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-36385211
3.
A Prospective Study of Preemptive Tenofovir Disoproxil Fumarate Therapy in HBsAg-Positive Patients With Diffuse Large B-Cell Lymphoma Receiving Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone.
Am J Gastroenterol
; 118(8): 1373-1380, 2023 08 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36728217
4.
Oral HDAC inhibitor tucidinostat in patients with relapsed or refractory peripheral T-cell lymphoma: phase IIb results.
Haematologica
; 108(3): 811-821, 2023 03 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36200417
5.
Diagnostic Accuracy and Prognostic Relevance of Immunoglobulin Heavy Chain Rearrangement and 18F-FDG-PET/CT Compared With Unilateral Bone Marrow Trephination for Detecting Bone Marrow Involvement in Patients With Diffuse Large B-Cell Lymphoma.
J Korean Med Sci
; 37(1): e2, 2022 Jan 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-34981678
6.
Clinical characteristics and prognostic factors of acquired haemophilia A in Korea.
Haemophilia
; 27(5): e609-e616, 2021 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-34156738
7.
Next-generation sequencing-based posttransplant monitoring of acute myeloid leukemia identifies patients at high risk of relapse.
Blood
; 132(15): 1604-1613, 2018 10 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-30108064
8.
Endothelial activation and stress index (EASIX) is a reliable predictor for overall survival in patients with multiple myeloma.
BMC Cancer
; 20(1): 803, 2020 Aug 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-32831058
9.
Long-term follow-up of abbreviated R-CHOP chemoimmunotherapy for completely resected limited-stage diffuse large B cell lymphoma (CISL 12-09).
Ann Hematol
; 99(12): 2831-2836, 2020 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-32989495
10.
A phase II study of ibrutinib in combination with rituximab-cyclophosphamide-doxorubicin hydrochloride-vincristine sulfate-prednisone therapy in Epstein-Barr virus-positive, diffuse large B cell lymphoma (54179060LYM2003: IVORY study): results of the final analysis.
Ann Hematol
; 99(6): 1283-1291, 2020 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-32333154
11.
Prognostic significance of FDG-PET/CT in determining upfront autologous stem cell transplantation for the treatment of peripheral T cell lymphomas.
Ann Hematol
; 99(1): 83-91, 2020 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-31807859
12.
Clinical features and treatment outcomes of limited-stage mantle cell lymphoma: Consortium for Improving Survival of Lymphoma report.
Ann Hematol
; 99(2): 223-228, 2020 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-31853704
13.
18F-FDG PET/CT is useful for determining survival outcomes of patients with multiple myeloma classified as stage II and III with the Revised International Staging System.
Eur J Nucl Med Mol Imaging
; 46(1): 107-115, 2019 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30187105
14.
Optimal chemo-mobilization for the collection of peripheral blood stem cells in patients with multiple myeloma.
BMC Cancer
; 19(1): 59, 2019 Jan 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-30642286
15.
Efficacy and safety of blinatumomab treatment in adult Korean patients with relapsed/refractory acute lymphoblastic leukemia on behalf of the Korean Society of Hematology ALL Working Party.
Ann Hematol
; 98(1): 151-158, 2019 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-30259121
16.
Allogeneic Stem Cell Transplantation for Patients with Natural Killer/T Cell Lymphoid Malignancy: A Multicenter Analysis Comparing Upfront and Salvage Transplantation.
Biol Blood Marrow Transplant
; 24(12): 2471-2478, 2018 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-30064012
17.
Correction to: a risk stratification model for nodal peripheral T-cell lymphomas based on the NCCN-IPI and posttreatment Deauville score.
Eur J Nucl Med Mol Imaging
; 45(13): 2482-2483, 2018 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-30221329
18.
A risk stratification model for nodal peripheral T-cell lymphomas based on the NCCN-IPI and posttreatment Deauville score.
Eur J Nucl Med Mol Imaging
; 45(13): 2274-2284, 2018 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-30056546
19.
Clinical response and pharmacokinetics of bendamustine as a component of salvage R-B(O)AD therapy for the treatment of primary central nervous system lymphoma (PCNSL).
BMC Cancer
; 18(1): 729, 2018 Jul 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-29986691
20.
Nilotinib combined with multiagent chemotherapy for newly diagnosed Philadelphia-positive acute lymphoblastic leukemia.
Blood
; 126(6): 746-56, 2015 Aug 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-26065651